Deficiency of FK506-binding protein (FKBP) 51 alters sleep architecture and recovery sleep responses to stress in mice

Journal of Sleep Research

Volumn 23, Issue 2, 2014, Pages 176-185

  Albu, Stefana ^a   Romanowski, Christoph P N ^a   Letizia Curzi, M ^a   Jakubcakova, Vladimira ^a   Flachskamm, Cornelia ^a   Gassen, Nils C ^a   Hartmann, Jakob ^a   Schmidt, Mathias V ^a   Schmidt, Ulrike ^a   Rein, Theo ^a   Holsboer, Florian ^a   Hausch, Felix ^a   Paez Pereda, Marcelo ^a   Kimura, Mayumi ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Depression; FKBP51; Free corticosterone; Rapid eye movement sleep; Restraint stress; Slow wave activity

Indexed keywords

CORTICOSTERONE; FK 506 BINDING PROTEIN; FK506 BINDING PROTEIN 51; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; MALE; MOUSE; NONHUMAN; NONREM SLEEP; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTEIN FUNCTION; REM SLEEP; SLEEP; SLEEP DEPRIVATION; SLEEP WAKING CYCLE; SLOW BRAIN WAVE; SLOW WAVE SLEEP;

DEPRESSION; FKBP51; FREE CORTICOSTERONE; RAPID EYE MOVEMENT SLEEP; RESTRAINT STRESS; SLOW-WAVE ACTIVITY;

ANIMALS; CORTICOSTERONE; DEPRESSIVE DISORDER; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MICE; MICE, KNOCKOUT; PITUITARY-ADRENAL SYSTEM; POLYMORPHISM, GENETIC; POLYSOMNOGRAPHY; SLEEP; SLEEP DEPRIVATION; SLEEP DISORDERS; SLEEP, REM; TACROLIMUS BINDING PROTEINS;

EID: 84896047974     PISSN: 09621105     EISSN: 13652869     Source Type: Journal    
DOI: 10.1111/jsr.12112     Document Type: Article

References (34)

1. Attwood, B. K., Bourgognon, J. M., Patel, S. et al. Neuropsin cleaves EphB2 in the amygdala to control anxiety. Nature, 2011, 473: 372-375.
2. Binder, E. B. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology, 2009, 34(Suppl. 1): S186-S195.
3. Binder, E. B., Salyakina, D., Lichtner, P. et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat. Genet., 2004, 36: 1319-1325.
4. Borbely, A. A. and Achermann, P. Sleep homeostasis and models of sleep regulation. J. Biol. Rhythms, 1999, 14: 557-568.
5. Bouyer, J. J., Vallee, M., Deminiere, J. M., Le Moal, M. and Mayo, W. Reaction of sleep-wakefulness cycle to stress is related to differences in hypothalamo-pituitary-adrenal axis reactivity in rat. Brain Res., 1998, 804: 114-124.
6. Buckley, T. M. and Schatzberg, A. F. On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J. Clin. Endocrinol. Metab., 2005, 90: 3106-3114.
7. Davies, T. H., Ning, Y. M. and Sanchez, E. R. A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins. J. Biol. Chem., 2002, 277: 4597-4600.
8. De Kloet, E. R., Joels, M. and Holsboer, F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci., 2005, 6: 463-475.
9. Denny, W. B., Valentine, D. L., Reynolds, P. D., Smith, D. F. and Scammell, J. G. Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology, 2000, 141: 4107-4113.
10. Evrard, A., Barden, N., Hamon, M. and Adrien, J. Glucocorticoid receptor-dependent desensitization of 5-HT1A autoreceptors by sleep deprivation: studies in GR-i transgenic mice. Sleep, 2006, 29: 31-36.
11. Hartmann, J., Wagner, K. V., Liebl, C. et al. The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharmacology, 2012, 62: 332-339.
12. Herr, A. S., Wochnik, G. M., Rosenhagen, M. C., Holsboer, F. and Rein, T. Rifampicin is not an activator of glucocorticoid receptor. Mol. Pharmacol., 2000, 57: 732-737.
13. Holsboer, F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology, 2000, 23: 477-501.
14. Kimura, M., Muller-Preuss, P., Lu, A. et al. Conditional corticotropin-releasing hormone overexpression in the mouse forebrain enhances rapid eye movement sleep. Mol. Psychiatry, 2010, 15: 154-165.
15. Linthorst, A. C. and Reul, J. M. Stress and the brain: solving the puzzle using microdialysis. Pharmacol. Biochem. Behav., 2008, 90: 163-173.
16. Linthorst, A. C., Flachskamm, C., Barden, N., Holsboer, F. and Reul, J. M. Glucocorticoid receptor impairment alters CNS responses to a psychological stressor: an in vivo microdialysis study in transgenic mice. Eur. J. Neurosci., 2000, 12: 283-291.
17. Mongrain, V., Hernandez, S. A., Pradervand, S. et al. Separating the contribution of glucocorticoids and wakefulness to the molecular and electrophysiological correlates of sleep homeostasis. Sleep, 2010, 33: 1147-1157.
18. Montkowski, A., Barden, N., Wotjak, C. et al. Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function. J. Neuroendocrinol., 1995, 7: 841-845.
19. O'Leary, J. C. III, Dharia, S., Blair, L. J. et al. A new anti-depressive strategy for the elderly: ablation of FKBP5/FKBP51. PLoS ONE, 2011, 6: e24840.
20. Penalva, R. G., Flachskamm, C., Zimmermann, S. et al. Corticotropin-releasing hormone receptor type 1-deficiency enhances hippocampal serotonergic neurotransmission: an in vivo microdialysis study in mutant mice. Neuroscience, 2002, 109: 253-266.
21. Pepin, M. C., Pothier, F. and Barden, N. Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature, 1992, 355: 725-728.
22. Przegalinski, E. and Budziszewska, B. The effect of long-term treatment with antidepressant drugs on the hippocampal mineralocorticoid and glucocorticoid receptors in rats. Neurosci. Lett., 1993, 161: 215-218.
23. Reul, J. M., Stec, I., Soder, M. and Holsboer, F. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology, 1993, 133: 312-320.
24. Scharf, S. H., Liebl, C., Binder, E. B., Schmidt, M. V. and Muller, M. B. Expression and regulation of the Fkbp5 gene in the adult mouse brain. PLoS ONE, 2011, 6: e16883.
25. Schmidt, M. V., Paez-Pereda, M., Holsboer, F. and Hausch, F. The prospect of FKBP51 as a drug target. Chem. Med. Chem., 2012, 7: 1351-1359.
26. Seckl, J. R. and Fink, G. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology, 1992, 55: 621-626.
27. Steiger, A. and Kimura, M. Wake and sleep EEG provide biomarkers in depression. J. Psychiatr. Res., 2010, 44: 242-252.
28. Tatro, E. T., Everall, I. P., Kaul, M. and Achim, C. L. Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder. Brain Res., 2009, 1286: 1-12.
29. Touma, C., Gassen, N. C., Herrmann, L. et al. FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior. Biol. Psychiatry, 2011, 70: 928-936.
30. Tranguch, S., Cheung-Flynn, J., Daikoku, T. et al. Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation. Proc. Natl Acad. Sci. USA, 2005, 102: 14326-14331.
31. Wang, Y., Kirschner, A., Fabian, A. K. et al. Increasing the efficiency of ligands for FK506-binding protein 51 by conformational control. J. Med. Chem., 2013, 56: 3922-3935.
32. Wirz-Justice, A. and Van Den Hoofdakker, R. H. Sleep deprivation in depression: what do we know, where do we go? Biol. Psychiatry, 1999, 46: 445-453.
33. Wochnik, G. M., Ruegg, J., Abel, G. A., Schmidt, U., Holsboer, F. and Rein, T. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J. Biol. Chem., 2005, 280: 4609-4616.
34. Zobel, A., Schuhmacher, A., Jessen, F. et al. DNA sequence variants of the FKBP5 gene are associated with unipolar depression. Int. J. Neuropsychopharmacol., 2010, 13: 649-660.